Cellcom Israel, Ltd. (OTCMKTS:CELJF - Get Free Report)'s stock price reached a new 52-week high on Thursday . The stock traded as high as $9.10 and last traded at $8.91, with a volume of 2870 shares trading hands. The stock had previously closed at $8.38.
Analysts Set New Price Targets
Separately, Wall Street Zen raised shares of Cellcom Israel to a "strong-buy" rating in a report on Sunday, July 20th.
Read Our Latest Report on Cellcom Israel
Cellcom Israel Stock Up 6.4%
The firm has a market capitalization of $1.46 billion, a PE ratio of 24.75 and a beta of 0.91. The company's fifty day simple moving average is $7.60 and its 200 day simple moving average is $6.93. The company has a quick ratio of 0.60, a current ratio of 0.67 and a debt-to-equity ratio of 0.44.
Cellcom Israel (OTCMKTS:CELJF - Get Free Report) last posted its quarterly earnings data on Wednesday, June 25th. The company reported $0.09 EPS for the quarter. The firm had revenue of $300.50 million for the quarter. Cellcom Israel had a return on equity of 9.26% and a net margin of 5.11%.
Cellcom Israel Company Profile
(
Get Free Report)
Cellcom Israel Ltd. provides cellular communications services in Israel. It operates in two segments, Cellular and Fixed-line. The Cellular segment offers cellular communications, and cellular equipment and related services. The Fixed-line segment provides infrastructure and internet access, internet-based television, international telephony, landline telephony services, and transmission services for business customers and for telecommunication operators; and conferencing, cloud computing, and server hosting services, as well as IOT solutions.
See Also
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Cellcom Israel, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cellcom Israel wasn't on the list.
While Cellcom Israel currently has a Sell rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.